Yiming Zhao

3.9k total citations · 1 hit paper
102 papers, 2.9k citations indexed

About

Yiming Zhao is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yiming Zhao has authored 102 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 28 papers in Immunology and 26 papers in Cancer Research. Recurrent topics in Yiming Zhao's work include Reproductive System and Pregnancy (11 papers), Cancer-related molecular mechanisms research (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Yiming Zhao is often cited by papers focused on Reproductive System and Pregnancy (11 papers), Cancer-related molecular mechanisms research (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Yiming Zhao collaborates with scholars based in China, United States and Canada. Yiming Zhao's co-authors include Jia Fan, Zhi Dai, Shao‐Lai Zhou, Zheng‐Jun Zhou, Jian Zhou, Hao Wang, Zhen‐Bin Ding, De-Ning Ma, Weiping Zhu and Ning Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Yiming Zhao

101 papers receiving 2.9k citations

Hit Papers

Phase 1b Study of Sintili... 2021 2026 2022 2024 2021 50 100 150

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yiming Zhao 1.4k 679 660 545 463 102 2.9k
Bing Xu 1.5k 1.1× 482 0.7× 693 1.1× 452 0.8× 295 0.6× 192 3.1k
Claudia Goettsch 2.0k 1.5× 634 0.9× 572 0.9× 780 1.4× 578 1.2× 77 4.2k
Arántzazu Alfranca 1.5k 1.1× 814 1.2× 772 1.2× 737 1.4× 372 0.8× 70 3.3k
Ting Zhao 1.5k 1.1× 792 1.2× 482 0.7× 695 1.3× 274 0.6× 105 2.9k
Anthony W. Ashton 1.8k 1.3× 575 0.8× 498 0.8× 507 0.9× 270 0.6× 87 3.7k
Nathalie Théret 1.4k 1.0× 649 1.0× 755 1.1× 550 1.0× 329 0.7× 87 3.4k
Jian Xu 1.8k 1.3× 888 1.3× 420 0.6× 472 0.9× 317 0.7× 112 3.0k
Michał Mikuła 1.6k 1.1× 471 0.7× 474 0.7× 302 0.6× 336 0.7× 135 2.7k

Countries citing papers authored by Yiming Zhao

Since Specialization
Citations

This map shows the geographic impact of Yiming Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Zhao more than expected).

Fields of papers citing papers by Yiming Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Zhao. The network helps show where Yiming Zhao may publish in the future.

Co-authorship network of co-authors of Yiming Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Zhao. A scholar is included among the top collaborators of Yiming Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Zhao. Yiming Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhao, Yiming, et al.. (2023). Targeting cathepsin L in the regulation of apoptosis in peripheral T-cell lymphoma. Molecular & Cellular Toxicology. 20(3). 541–552. 1 indexed citations
4.
Zhao, Yiming, Hanlin Zhang, Zhizhuang Joe Zhao, et al.. (2023). Efficacy and safety of Oral LL‐37 against the Omicron BA.5.1.3 variant of SARS‐COV‐2: A randomized trial. Journal of Medical Virology. 95(8). e29035–e29035. 6 indexed citations
5.
Fan, Shasha, Zhenhai Lin, Yong‐Fa Zhang, et al.. (2023). ZNF655 promotes the progression of hepatocellular carcinoma through PSMB8. Cell Biology International. 47(9). 1535–1546. 4 indexed citations
6.
Li, Shengli, Yiming Zhao, Yizhe Liu, et al.. (2022). Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature. Cell Death and Disease. 13(8). 732–732. 12 indexed citations
7.
Zhao, Yiming, Hongda Wang, Xiang Li, et al.. (2022). Galectin-9 Mediates the Therapeutic Effect of Mesenchymal Stem Cells on Experimental Endotoxemia. Frontiers in Cell and Developmental Biology. 10. 700702–700702. 5 indexed citations
8.
He, Xigan, Jiamin Zhou, Anrong Mao, et al.. (2022). LncRNA‐EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src‐YAP signaling axis. The FASEB Journal. 36(12). e22663–e22663. 9 indexed citations
9.
Zhou, Jiamin, Miao Wang, Anrong Mao, et al.. (2021). Long noncoding RNA MALAT1 sponging miR-26a-5p to modulate Smad1 contributes to colorectal cancer progression by regulating autophagy. Carcinogenesis. 42(11). 1370–1379. 31 indexed citations
10.
Qin, Yafei, Guangming Li, Yiming Zhao, et al.. (2021). Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy. Frontiers in Immunology. 12. 5 indexed citations
11.
Chu, Tianqing, Runbo Zhong, Hua Zhong, et al.. (2021). Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC. Journal of Thoracic Oncology. 16(4). 643–652. 174 indexed citations breakdown →
12.
Li, Xiang, Hongyue Li, Yiming Zhao, et al.. (2020). IL-37 Gene Modification Enhances the Protective Effects of Mesenchymal Stromal Cells on Intestinal Ischemia Reperfusion Injury. Stem Cells International. 2020. 1–12. 10 indexed citations
13.
Qin, Yafei, Jin Wang, Xiang Li, et al.. (2020). CD73 expression is critical to therapeutic effects of human endometrial regenerative cells in inhibition of cardiac allograft rejection in mice. Stem Cells Translational Medicine. 10(3). 465–478. 11 indexed citations
14.
Zhao, Yiming, Xiang Li, Yafei Qin, et al.. (2020). Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice. Stem Cell Research & Therapy. 11(1). 471–471. 13 indexed citations
15.
Wu, Yangjun, Yiming Zhao, Lin Huan, et al.. (2019). An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin. Cancer Research. 80(5). 976–987. 46 indexed citations
16.
Zheng, Qiupeng, Jingjing Zhao, Hui Yu, et al.. (2019). Tumor‐Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function. Hepatology. 71(1). 259–274. 18 indexed citations
17.
Xu, Lan, Grace Wang, Baoren Zhang, et al.. (2018). B7-H1 Expression Is Required for Human Endometrial Regenerative Cells in the Prevention of Transplant Vasculopathy in Mice. Stem Cells International. 2018. 1–12. 11 indexed citations
18.
Zhao, Yiming, Lan Xu, Yong Wang, et al.. (2018). Human Endometrial Regenerative Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis in Mice. Stem Cells International. 2018. 1–13. 32 indexed citations
19.
Zhou, Zheng‐Jun, Zhi Dai, Shao‐Lai Zhou, et al.. (2014). HNRNPAB Induces Epithelial–Mesenchymal Transition and Promotes Metastasis of Hepatocellular Carcinoma by Transcriptionally Activating SNAIL. Cancer Research. 74(10). 2750–2762. 88 indexed citations
20.
Zhu, Kai, Zhi Dai, Qi Pan, et al.. (2011). Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition. Clinical Cancer Research. 17(23). 7294–7302. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026